These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1399682)

  • 1. Preparation of 123I-labeled 2'-iodospiperone and imaging of D2 dopamine receptors in the human brain using SPECT.
    Saji H; Iida Y; Magata Y; Yonekura Y; Iwasaki Y; Sasayama S; Konishi J; Nakatsuka I; Shiba K; Yoshitake A
    Int J Rad Appl Instrum B; 1992 Jul; 19(5):523-9. PubMed ID: 1399682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SPECT imaging of dopamine D2 receptors with 2'-iodospiperone.
    Iwasaki Y; Yonekura Y; Saji H; Nishizawa S; Fukuyama H; Iida Y; Magata Y; Shibasaki H; Yokoyama A; Konishi J
    J Nucl Med; 1995 Jul; 36(7):1191-5. PubMed ID: 7790943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Initial clinical experiences with dopamine D2 receptor imaging by means of 2'-iodospiperone and single-photon emission computed tomography.
    Yonekura Y; Saji H; Iwasaki Y; Tsuchida T; Fukuyama H; Shimatsu A; Iida Y; Magata Y; Konishi J; Yokoyama A
    Ann Nucl Med; 1995 Aug; 9(3):131-6. PubMed ID: 8534585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of the three radioiodinated dopamine D2 receptor ligands [123I]IBF, [123I]epidepride and [123I]2'-ISP in nonhuman primates.
    Baldwin RM; Zea-Ponce Y; Zoghbi SS; al-Tikriti MS; Seibyl JP; Sybirska EH; Malison RT; Laruelle M; Charney DS; Hoffer PB
    Nucl Med Biol; 1994 Oct; 21(7):969-76. PubMed ID: 9234352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardial accumulation of a dopamine D2 receptor-binding radioligand, 2'-iodospiperone.
    Saji H; Yonekura Y; Tanahashi K; Iida Y; Iwasaki Y; Magata Y; Konishi J; Yokoyama A
    Ann Nucl Med; 1993 Aug; 7(3):153-6. PubMed ID: 7692910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iodoethylspiperone, a new potential agent for exploration of central dopamine D2 receptors: synthesis and preliminary in vivo study.
    Chalon S; Frangin Y; Guilloteau D; Caillet M; Guimbal C; Schmitt MH; Desplanches G; Baulieu JL; Besnard JC
    Int J Rad Appl Instrum B; 1990; 17(4):389-95. PubMed ID: 2143754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of three high affinity SPECT radiotracers for the dopamine D2 receptor.
    al-Tikriti MS; Baldwin RM; Zea-Ponce Y; Sybirska E; Zoghbi SS; Laruelle M; Malison RT; Kung HF; Kessler RM; Charney DS
    Nucl Med Biol; 1994 Feb; 21(2):179-88. PubMed ID: 9234281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of N-alkyl derivatives of radioiodinated spiperone as radioligands for in vivo dopamine D2 receptor studies: effects of lipophilicity and receptor affinity on the in vivo biodistribution.
    Saji H; Tokui T; Nakatsuka I; Saiga A; Magata Y; Shiba K; Yoshitake A; Yokoyama A
    Chem Pharm Bull (Tokyo); 1992 Jan; 40(1):165-9. PubMed ID: 1576667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Technetium-99m spiperone dithiocarbamate: a potential radiopharmaceutical for dopamine receptor imaging with SPECT.
    Ballinger JR; Gulenchyn KY; Hassan MN
    Int J Rad Appl Instrum A; 1989; 40(6):547-9. PubMed ID: 2551854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [In vivo characteristics of IBZM in rat brains: an agent for quantitative SPECT imaging of dopamine D2 receptors. Preparation of 125I-IBZM and its biodistribution and kinetic properties].
    Matsumura K; Toyama H; Nakashima H; Ichise M; Kurami M; Nakagawa T; Maeda H; Takeuchi A; Koga S
    Kaku Igaku; 1994 May; 31(5):513-9. PubMed ID: 8028224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of in vitro binding properties of a series of dopamine antagonists and agonists for cloned human dopamine D2S and D2L receptors and for D2 receptors in rat striatal and mesolimbic tissues, using [125I] 2'-iodospiperone.
    Leysen JE; Gommeren W; Mertens J; Luyten WH; Pauwels PJ; Ewert M; Seeburg P
    Psychopharmacology (Berl); 1993; 110(1-2):27-36. PubMed ID: 7870895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, in vitro binding profile and biodistribution of a 125I-labeled N-benzyl pyrrolidinyl benzamide derivative: a potential radioligand for mapping dopamine D2 receptors.
    Saji H; Tanahashi K; Kinoshita T; Iida Y; Magata Y; Yokoyama A
    Nucl Med Biol; 1996 Feb; 23(2):121-7. PubMed ID: 8868283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radioiodinated 2'-iodospiperone: a new radioligand for in vivo dopamine receptor study.
    Saji H; Nakatsuka I; Shiba K; Tokui T; Horiuchi K; Yoshitake A; Torizuka K; Yokoyama A
    Life Sci; 1987 Oct; 41(17):1999-2006. PubMed ID: 3669906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. (3-N-[11C]methyl)spiperone, a ligand binding to dopamine receptors: radiochemical synthesis and biodistribution studies in mice.
    Burns HD; Dannals RF; Langström B; Ravert HT; Zemyan SE; Duelfer T; Wong DF; Frost JJ; Kuhar MJ; Wagner HN
    J Nucl Med; 1984 Nov; 25(11):1222-7. PubMed ID: 6333496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 4-[123I]iodospiperone as a ligand for dopamine DA receptors: in vitro and in vivo experiments in a rat model.
    Van der Krogt JA; Pauwels EK; Van Doremalen PA; Wijnhoven G; Reiffers S; Van Valkenburg CF; Buruma OJ
    Int J Rad Appl Instrum B; 1992 Oct; 19(7):759-63. PubMed ID: 1399697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Visualization of extrastriatal dopamine D2 receptors in the human brain.
    Kessler RM; Mason NS; Votaw JR; De Paulis T; Clanton JA; Ansari MS; Schmidt DE; Manning RG; Bell RL
    Eur J Pharmacol; 1992 Nov; 223(1):105-7. PubMed ID: 1478255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of [123I]IBZM pinhole SPECT for the detection of striatal dopamine D2 receptor availability in rats.
    Scherfler C; Scholz SW; Donnemiller E; Decristoforo C; Oberladstätter M; Stefanova N; Diederen E; Virgolini I; Poewe W; Wenning GK
    Neuroimage; 2005 Feb; 24(3):822-31. PubMed ID: 15652317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Phase 1 clinical study of 123I-IBF, a new radioligand for evaluating dopamine D2 receptor with SPECT (I); biodistribution and dosimetry].
    Yonekura Y; Sadato N; Tsuchida T; Uematsu H; Nakamura S; Yamamoto K; Ishii Y
    Kaku Igaku; 1999 Feb; 36(2):145-53. PubMed ID: 10213982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo SPECT imaging of CNS D-2 dopamine receptors: initial studies with iodine-123-IBZM in humans.
    Kung HF; Alavi A; Chang W; Kung MP; Keyes JW; Velchik MG; Billings J; Pan S; Noto R; Rausch
    J Nucl Med; 1990 May; 31(5):573-9. PubMed ID: 2140408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolism of [123I]epidepride may affect brain dopamine D2 receptor imaging with single-photon emission tomography.
    Bergström KA; Yu M; Kuikka JT; Akerman KK; Hiltunen J; Lehtonen J; Halldin C; Tiihonen J
    Eur J Nucl Med; 2000 Feb; 27(2):206-8. PubMed ID: 10755727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.